Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

UCR, CRF initiate PROSPECT II trial to identify plaques that may lead to coronary events

The Cardiovascular Research Foundation (CRF) of New York, NY and the Uppsala Clinical Research Center (UCR) of Uppsala, Sweden announced today the initiation of the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) II trial and the PROSPECT ABSORB sub study.

29 Oct 2013

Patients with severe rheumatoid arthritis more likely to have heart problems

People with rheumatoid arthritis and other chronic inflammatory conditions are at higher risk of heart disease. Who is in the most danger, why and how best to prevent and detect cardiovascular complications are important questions for physicians and researchers.

28 Oct 2013

Researchers publish comprehensive review of the benefits, risks of daily aspirin dosage

Researchers at Warwick Medical School have published the most comprehensive review of the benefits and risks of a daily dose of prophylactic aspirin and warn that greater understanding of side effects is needed.

25 Oct 2013

New study finds association between OSA and subclinical myocardial injury

Obstructive sleep apnea is known to be associated with an increased incidence of cardiovascular disease. Now a new study indicates that OSA is associated with subclinical myocardial injury, as indicated by increased high sensitivity troponin T levels. Elevated hs-TnT levels are predictive of both coronary heart disease and heart failure in the general population.

25 Oct 2013

HIV-positive patients with high CD4 cell counts are not at increased risk for heart attacks

Patients who are HIV-positive and have high CD4 cell counts - or have a high number of white blood cells that fight infections - aren't at an increased risk for heart attacks compared to patients who are HIV-negative, according to a Kaiser Permanente study that appears in the current online issue of the Journal of Acquired Immune Deficiency Syndromes.

25 Oct 2013

Researchers reveal why sleep deprivation increases risk of cardiovascular disease, type 2 diabetes

The fact that sleep deprivation has an impact on the function of the human immune system is well known. In their latest study, the University of Helsinki research group Sleep Team has now discovered new biological links between sleep loss and the immune system. The results provide at least a partial explanation of why sleep deprivation increases the risk of cardiovascular disease and type 2 diabetes.

24 Oct 2013

Testosterone treatment in hypogonadal men may reduce cardiovascular disease risk

Research from Boston University School of Medicine suggests that testosterone treatment in hypogonadal (testosterone deficient) men restores normal lipid profiles and may reduce the risk of cardiovascular disease. These finding currently appear online in the International Journal of Clinical Practice.

24 Oct 2013

Carcinogens detected in emissions downwind of 'Industrial Heartland'

Levels of contaminants higher than in some of the world's most polluted cities have been found downwind of Canada's largest oil, gas and tar sands processing zone, in a rural area where men suffer elevated rates of cancers linked to such chemicals.

23 Oct 2013

CoLucid signs distribution and supply agreement with ILDONG for Lasmiditan

CoLucid Pharmaceuticals, Inc., and ILDONG Pharmaceutical Co., Ltd., announced today that they have entered into a distribution and supply agreement for Lasmiditan in South Korea and Southeast Asia.

23 Oct 2013

diaDexus amends agreement with Comerica Bank to expand existing loan facility

diaDexus, Inc., a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it has amended its agreement with Comerica Bank to expand its existing loan facility from $5 million to $10 million.

22 Oct 2013

RMA of New York partners with Mount Sinai Medical Center to study long-term effects of PCOS

Reproductive Medicine Associates of New York is proud to announce their partnership with Mount Sinai Medical Center on a study that will examine the long-term effects of PCOS on children born to mothers who have been diagnosed with this condition.

22 Oct 2013

Buck Institute finds link between ApoE4 and anti-aging protein targeted by resveratrol in red wine

he major genetic risk factor for Alzheimer's disease (AD), present in about two-thirds of people who develop the disease, is ApoE4, the cholesterol-carrying protein that about a quarter of us are born with. But one of the unsolved mysteries of AD is how ApoE4 causes the risk for the incurable, neurodegenerative disease.

22 Oct 2013

Hereditary high blood cholesterol overlooked and untreated worldwide

Hereditary high blood cholesterol leads to premature heart disease. It is overlooked and untreated virtually worldwide -- including in Europe. This is a major problem as the disease is dangerous for health. However, this disease is easy to diagnose and treat, according to the conclusion of a consensus report from the European Atherosclerosis Society.

21 Oct 2013

Community health awareness delivered by paramedics leads to 32% reduction in EMS calls

Emergency Medical Service (EMS) staff are accustomed to responding to emergencies. A study presented today at the Canadian Cardiovascular Congress finds they may be able to prevent many emergencies as well, judging by the preliminary success of a pilot project at a Hamilton building for seniors.

19 Oct 2013

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults. ZORVOLEX was approved at dosage strengths that are 20 percent lower than currently available diclofenac products.

19 Oct 2013

High-intensity interval training with Mediterranean diet counselling 'supersizes' heart health

Lifestyle programs focused on high-intensity interval training combined with nutritional counselling on the Mediterranean diet have shown dramatic results for improving the heart health of people with abdominal obesity, finds a study released at the Canadian Cardiovascular Congress.

18 Oct 2013

Health care practitioners should focus on getting calcium from diet, says researcher

In recent years, studies have reported inconsistent findings regarding whether calcium supplements used to prevent fractures increase the risk of heart attack.

18 Oct 2013

Researchers find 5-fold increase in high cholesterol risk

What leads to high cholesterol? Your genes and lifestyle factors may not explain it all. A study presented today at the Canadian Cardiovascular Congress has connected some of the risk for high cholesterol in adults to their mother's cholesterol levels before she even became pregnant.

17 Oct 2013

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.

16 Oct 2013

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

The impact of bariatric surgery on risk factors for cardiovascular disease depends on a variety of factors, including the type of surgery, sex of the patient, ethnic background, and pre-surgery body mass index, according to a Kaiser Permanente study published today in Annals of Surgery.

16 Oct 2013

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

UCR, CRF initiate PROSPECT II trial to identify plaques that may lead to coronary events

Patients with severe rheumatoid arthritis more likely to have heart problems

Researchers publish comprehensive review of the benefits, risks of daily aspirin dosage

New study finds association between OSA and subclinical myocardial injury

HIV-positive patients with high CD4 cell counts are not at increased risk for heart attacks

Researchers reveal why sleep deprivation increases risk of cardiovascular disease, type 2 diabetes

Testosterone treatment in hypogonadal men may reduce cardiovascular disease risk

Carcinogens detected in emissions downwind of 'Industrial Heartland'

CoLucid signs distribution and supply agreement with ILDONG for Lasmiditan

diaDexus amends agreement with Comerica Bank to expand existing loan facility

RMA of New York partners with Mount Sinai Medical Center to study long-term effects of PCOS

Buck Institute finds link between ApoE4 and anti-aging protein targeted by resveratrol in red wine

Hereditary high blood cholesterol overlooked and untreated worldwide

Community health awareness delivered by paramedics leads to 32% reduction in EMS calls

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

High-intensity interval training with Mediterranean diet counselling 'supersizes' heart health

Health care practitioners should focus on getting calcium from diet, says researcher

Researchers find 5-fold increase in high cholesterol risk

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in